相关实验视频
Updated: Jun 23, 2025

06:14
Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
Published on: May 13, 2021
6.5K
在接受化疗的患者中感染口腔简单疹病毒 - 综合性审查
Aristéa Ribeiro Carvalho1, Renan Lemos da Silva2, Ed Campos Vieira Neto3
1Department of Surgery, Stomatology, Pathology and Radiology, Bauru School of Dentistry, University of São Paulo, Bauru, Brazil.
GMS hygiene and infection control
|June 17, 2024
概括
口腔疹简单病毒 (HSV) 感染很常见,在接受化疗 (CT) 的患者中可能是严重的. 早期的抗病毒治疗对于免疫受损患者来说至关重要,以防止并发症.
科学领域:
- 在瘤学瘤学.
- 传染性疾病 传染性疾病
- 口腔医学是指口腔医学.
背景情况:
- 化疗 (CT) 可以损害免疫系统,增加对机会性感染的易感性.
- 口腔疹简单病毒 (HSV) 的重新激活是免疫功能低下患者群体的一个重大问题.
- 了解化学疗法患者口服HSV的患病率和影响对于临床管理至关重要.
研究的目的:
- 在接受化疗 (CT) 的患者中进行口腔HSV感染的综合性文献审查.
- 为了确定这种患者群体中口服HSV的患病率,病因和再激活模式.
- 为了告知医疗保健专业人员关于风险和口服HSV在CT期间的管理.
主要方法:
- 系统地搜索主要的科学数据库:PubMed/MEDLINE,Embase,虚拟健康图书馆和Scopus.
- 使用的关键词:"简单疹"",病毒性疾病"",口腔"和"抗瘤剂".
- 综合性文献审查方法论,以综合发现.
主要成果:
- 口服HSV感染在接受化疗 (CT) 的患者中很普遍.
- 在这个人群中,HSV感染可能是严重和频繁的.
- 建议及早启动抗病毒疗法,以减轻免疫功能低下患者的并发症.
结论:
- 医疗保健专业人员必须充分了解CT患者口服HSV的风险和治疗选择.
- 根据个体患者的情况,需要量身定制的治疗策略.
- 需要进一步进行严格的研究,以准确量化化疗接受者的口服HSV患病率.
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
159
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
159
Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
192
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
192

